INO

Jacqueline Elizabeth Shea

Known title: Chief Operating OfficerCIK: 0001771498

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

INO: PGEN AdenoVerse Pipeline May Drive Growth Beyond Papzimeos. The article examines whether PGEN’s AdenoVerse platform can generate growth that surpasses the company’s current Papzimeos product line. It highlights the potential of the pipeline to broaden Inovio’s therapeutic offerings. The discussion comes as the stock sits near its 16‑touch support level of $1.07 and a neutral RSI of 45.6. Analysts still target the shares at around $3.17 on average.

this person other insiders at INO

Transaction History

INO▲ Buy—
INO▼ Sell$15K
INO▲ Buy—
INO▼ Sell$10K
INO▲ Buy—
INO▼ Sell$14K
INO▲ Buy—
INO▼ Sell$24K
INO▲ Buy—
INO▼ Sell$15K
INO▼ Sell$4K
INO▲ Buy—
INO▲ Buy—
INO▲ Buy—
INO▼ Sell$5K
INO▼ Sell$18K
INO▲ Buy—
INO▼ Sell$101K
INO▲ Buy—
INO▼ Sell$25K
INO▼ Sell$7K
INO▲ Buy—
INO▼ Sell$23K
INO▲ Buy—
INO▼ Sell$23K
INO▲ Buy—
INO▲ Buy—
INO▼ Sell$29K
INO▲ Buy—
INO▼ Sell$13K
INO▲ Buy—
INO▼ Sell$42K
INO▲ Buy—
INO▼ Sell$26K
INO▼ Sell$84K
INO▲ Buy—
INO▲ Buy—
INO▼ Sell$35K

We use analytics to understand how market-wall is used. No personal data is sold.